The main purpose of this study is to determine the effectiveness of a new combination therapy
for actinic keratosis. This study investigates a new indication for an FDA-approved topical
medication, calcipotriol, for treatment of actinic keratosis, including how well it works and
how safe it is when used in combination with the standard of care medication (5-fluorouracil)
for the skin condition.